gate-Startup OncoBeta® receives Corporate Excellence Award 2019

OncoBeta recognized as the Most Compassionate Skin Cancer Therapy Provider in 2019

ID: 1554548
recent pressrelease next pressrelease

(PresseBox) - OncoBetancubator gate in Garching, Munich.

CV Magazine?s annual Corporate Excellence Awards are handpicked by their dedicated research team based purely on the comprehensive analysis of both qualitative and quantitative research during the past 12 months. The awards are designed to celebrate excellence in a number of core industries across the business landscape, highlighting those who have truly gone above and beyond to succeed in their endeavors, continually innovating, growing and improving.

Corporate Vision is created by a highly experienced and passionate team of business experts, advisors and insiders dedicated to shine a spot on the brightest, best performing and most deserving companies around the world by carefully analyzing what each industry has to offer. Their business experts recognize the very best and promote the success of companies committed to innovation that had the best performance over the past year.

OncoBeta GmbH has been a gamechanger in the way non-melanoma skin cancer (NMSC) is treated. By always having the patientBeta GmbH - The global incidence of NMSC has been drastically increasing over the past few decades. The standard care options for NMSC are either painful, non-aesthetically desired or invasive. ?OncoBeta is part of the story trying to rectify this? -continues Shannon. With the Rhenium-SCT, OncoBeta is not only improving patient outcomes but is also ensuring scalability and patients access to this therapeutic solution.

For more information about the CV Magazine Awards:

https://www.cv-magazine.com/2019-aiming-to-improve-overall-patient-outcomes-and-experiences

About the Rhenium-SCT

The Rhenium-SCTually within a few weeks after treatment.

About OncoBeta

OncoBeta application and device management system in conformity with all health, safety, and environmental protection regulatory standards. OncoBeta`s outstanding work has already been rewarded with several international recognitions such as ?Top 20 MedTech Outlook Solution Provider in Europe?, ?Top 30 Ethi



Find out more about the Rhenium-SCThttps://www.oncobeta.com

Forward-looking statements

This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of OncoBeta?s control and which could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning OncoBeta?s plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. OncoBeta



More information:
http://https://



Keywords (optional):



Company information / Profile:

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 12/06/2019 - 08:59
Language: English
News-ID 1554548
Character count: 5602
Kontakt-Informationen:
Firma: gate Garchinger Technologie- und Gründerzentrum GmbH
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Garching bei München
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 259

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 436
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 38


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.